The growth of the global Preclinical CRO market is driven by several key factors. Increasing complexity and costs associated ...

Altogen Labs is a preclinical research organization specializing in the testing and evaluation of novel pharmacological and biological treatments, including novel anticancer therapies, medical ...

美迪西波士顿第二座研发中心，位于莱克星顿，与众多国际顶尖的生物技术企业和科研机构为邻，共同形成了一个高度活跃的生物医药创新生态圈。此研发中心的加入，不仅增强了美迪西在全球生物医药CRO领域的竞争力，也为集群内的产业协同与互补提供了新的契机，注入了持续的创新动力和市场活力。

PharmaLegacy Laboratories, a provider of in vitro and in vivo preclinical drug development services, has acquired BTS ...

Study found OV329 cleared and remained undetectable in the retina, eye, and brain tissues of mice, unlike vigabatrin which has repeatedly shown ...

Presentation of in vitro studies of RM-0256, a novel anti-PD-L1 antibody conjugated to IR700, which comprises a dual mode of photoimmunotherapy: depletion of PD-L1 expressing tumor cells and depletion ...

Getting more effective drugs for patients in need as quickly as possible should be the ultimate reward and objective.

Cassava's financial challenges and data integrity concerns remain critical. Learn why SAVA stock is rated a strong sell given ...

Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024Professor Bruce E. Sands, MD to present oral ...

EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting ...